Patent US5114918A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5114918A Expired / Lapsed US ⏱️ 0.0 years remaining

Endothelin antagonistic cyclic pentapeptides

Assignee: MSD KK
•
Filing: 1990-12-20
•
Granted: 1992-05-19
•
Expires: 2010-12-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 1. A cyclic pentapeptide of the formula: <MATH> wherein X<n> (n = 1-5) represent amino acid residues, respectively, and X<1> is DPhe, DTyr, DTha, DTza, DNal, DBta, DTrp, DTrp(O), DTrp(CHO) or DTrp((CH2)mCOR<1>) (wherein m is from 0 to 6, and R<1> is a hydroxyl group, a C1-C6 alkoxy group, an amino group or a C1-C6 monoalkylamino group, provided that when m = 0, R<1> is not a hydroxyl group), X<2> is DAsp, DGlu or DCys(O3H), X<3> is Pro, Hyp, Pip, Thz, beta Ala, or Gly, Ala, alpha Aba, Aib, Val, Nva, Leu, Ile, aIle, Nle, Met, Met(O), Met(O2), Phe, Tza, Tha, Tyr, Trp, His, Arg, Lys, Lys(CHO), Orn, Orn(CHO), Asn, Gln, Asp, Glu, Cys(O3H), Cys, Ser or Thr wherein a hydrogen atom on the alpha -amino group may be substituted by a C1-C6 alkyl or C3-C7 cycloalkyl group which may have an optional group selected from the group consisting of an imidazolyl group, a carboxyl group, a sulfo group and a hydroxyl group, X<4> is DAla, DThr, D alpha Aba, DVal, DNva, DLeu, DIle, DaIle, DNle, DtertLeu, DCpg, DChg, DDpg, DPen, Aib, Ac3c, Ac4c, Ac5c, Ac6c, Ac7c, or DPhg, DThg, DFug, DTzg or DItg wherein a hydrogen atom at the alpha -position may be substituted by a C1-C3 alkyl group, X<5> is Pro, Pip, Thz, or His, Ala, alpha Aba, Val, Nva, Leu, Ile, aIle, Nle, Met, C3al, C4al, C5al or C6al wherein a hydrogen atom on the alpha -amino group may be substituted by a C1-C6 alkyl group; or a pharmaceutically acceptable salt thereof.

Inventors

  • 👤 Kiyofumi Ishikawa
  • 👤 Takehiro Fukami
  • 👤 Takashi Hayama
  • 👤 Kenji Niiyama
  • 👤 Toshio Nagase
  • 👤 Toshiaki Mase
  • 👤 Kagari Fujita
  • 👤 Masaru Nishikibe
  • 👤 Masaki Ihara
  • 👤 Mitsuo Yano

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 17:33
CPC Classifications
C; C07; C07K; C07K7/00; C07K7/64; C07K14/00; C07K14/435; C07K14/575; C07K14/57536; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S530/00; Y10S530/80; Y10S930/00; Y10S930/01; Y10S930/27

Claims Analysis

Total Claims: 3
Claim 1
Independent Claim 312 words
A cyclic pentapeptide of the formula: cyclo (--X.sup.1 --X.sup.2 --X.sup.3 --X.sup.4 --X.sup.5 --) (I) wherein X n (n=1-5) represents amino acid residues, respectively, and X 1 is D-Phe, D-Tyr, D-Tha, D-Tza, D-Nal, D-Bta, D-Trp, D-Trp(O), D-Trp(CHO) or D-Trp((CH 2 ) m COR 1 ), wherein m is from 0 to 6, and R 1 is a hydroxyl group, a C 1 -C 6 alkoxy group, an amino group or a C 1 -C 6 monoalkylamino group, provided that when m=0, R 1 is not a hydroxyl group; X 2 is D-Asp, D-Glu, or D-Cys(O 3 H); X 3 is Pro, Hyp, Pip, Thz, β-Ala, Gly, Ala, α-Aba, Aib, Val, Nva, Leu, Ile, aIle, Nle, Met, Met(O), Met(O 2 ), Phe, Tza, Tha, Tyr, Trp, His, Arg, Lys, Lys(CHO), Orn, Orn(CHO), Asn, Gln, Asp, Glu, Cys(O 3 H), Cys, Ser or Thr wherein those α-amino acids having a hydrogen atom on the α-amino group are optionally substituted by a C 1 -C 6 alkyl or C 3 -C 7 cycloalkyl group which optionally has a group selected from the group consisting of an imidazolyl group, a carboxyl group, a sulfo group and a hydroxy group; X 4 is D-Ala, D-Thr, D-α-Aba, D-Val, D-Nva, D-Leu, D-Ile, D-aIle, D-Nle, D-tert-Leu, D-Cpg, D-Chg, D-Dpg, D-Pen, Aib, Ac 3 c, Ac 4 c, Ac 5 c, Ac 6 c, Ac 7 c, D-Phg, D-Thg, D-Fug, D-Tzg or D-Itg wherein those α-amino acids having a hydrogen atom at the α-position are optionally substituted by a C 1 -C 3 alkyl group; X 5 is Pro, Pip, Thz, His, Ala, α-Aba, Val, Nva, Leu, Ile, aIle, Nle, Met, C 3 al, C 4 al, C 5 al or C 6 al wherein those α-amino acids having hydrogen atom on the α-amino group are optionally substituted by a C 1 -C 6 alkyl group; or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 312 words
A cyclic pentapeptide of the formula: cyclo (--X.sup.1 --X.sup.2 --X.sup.3 --X.sup.4 --X.sup.5 --) (I) wherein X n (n=1-5) represents amino acid residues, respectively, and X 1 is D-Phe, D-Tyr, D-Tha, D-Tza, D-Nal, D-Bta, D-Trp, D-Trp(O), D-Trp(CHO) or D-Trp((CH 2 ) m COR 1 ), wherein m is from 0 to 6, and R 1 is a hydroxyl group, a C 1 -C 6 alkoxy group, an amino group or a C 1 -C 6 monoalkylamino group, provided that when m=0, R 1 is not a hydroxyl group; X 2 is D-Asp, D-Glu, or D-Cys(O 3 H); X 3 is Pro, Hyp, Pip, Thz, β-Ala, Gly, Ala, α-Aba, Aib, Val, Nva, Leu, Ile, aIle, Nle, Met, Met(O), Met(O 2 ), Phe, Tza, Tha, Tyr, Trp, His, Arg, Lys, Lys(CHO), Orn, Orn(CHO), Asn, Gln, Asp, Glu, Cys(O 3 H), Cys, Ser or Thr wherein those α-amino acids having a hydrogen atom on the α-amino group are optionally substituted by a C 1 -C 6 alkyl or C 3 -C 7 cycloalkyl group which optionally has a group selected from the group consisting of an imidazolyl group, a carboxyl group, a sulfo group and a hydroxy group; X 4 is D-Ala, D-Thr, D-α-Aba, D-Val, D-Nva, D-Leu, D-Ile, D-aIle, D-Nle, D-tert-Leu, D-Cpg, D-Chg, D-Dpg, D-Pen, Aib, Ac 3 c, Ac 4 c, Ac 5 c, Ac 6 c, Ac 7 c, D-Phg, D-Thg, D-Fug, D-Tzg or D-Itg wherein those α-amino acids having a hydrogen atom at the α-position are optionally substituted by a C 1 -C 3 alkyl group; X 5 is Pro, Pip, Thz, His, Ala, α-Aba, Val, Nva, Leu, Ile, aIle, Nle, Met, C 3 al, C 4 al, C 5 al or C 6 al wherein those α-amino acids having hydrogen atom on the α-amino group are optionally substituted by a C 1 -C 6 alkyl group; or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 31 words
A pharmaceutical composition comprising an effective amount of a cyclic pentapeptide of the formula (I) as defined in claim 1 or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier.

References Cited (Backward Citations)

EP0127899A1 Cited
EP0135722A2 Cited
US4981950A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-05-19 1995-11-18 1996-05-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-05-19 1999-11-18 2000-05-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-05-19 2003-11-18 2004-05-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag